Journal profile · INFECTIOUS DISEASES
Current Fungal Infection Reports
ISSN 1936-3761 · eISSN 1936-377X · Springer Nature · 4 issues per year
Current Fungal Infection Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.9 (journal website); hybrid open access; APC about USD 3,890; median 72 days to acceptance (30 articles, last 24 months); 20 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Fungal Infection Reports is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antifungal resistance and susceptibility, Fungal Infections and Studies and Nail Diseases and Treatments, together about 70.7% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
This journal intends to provide clear, insightful, balanced contributions that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of fungal infections. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as advances in diagnosis, current and emerging management approaches, and genomics and pathogenesis. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. Commentaries from well-known figures in the field are also provided, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Matt McCarthyPublisher website
Editorial board by country: 1 in mainland China (about 33%); most named Mexico 2, Mainland China 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antifungal resistance and susceptibilityMedicine32%
- Fungal Infections and StudiesMedicine27.8%
- Nail Diseases and TreatmentsMedicine10.8%
- Plant Pathogens and Fungal DiseasesBiochemistry, Genetics and Molecular Biology6.9%
- Infectious Diseases and MycologyVeterinary4.4%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine3.4%
- Antibiotics Pharmacokinetics and EfficacyMedicine1.7%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology1.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 1.11LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 193OpenAlex ·
- 2-year mean citedness
- 2.03OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 20%LetPub ·
Volume
- Articles per year
- 20LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 73,800Publisher website ·
Articles by year OpenAlex count · 615 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 7 | 6 |
| 2025 | 20 | 4 | 25 |
| 2024 | 21 | 5 | 101 |
| 2023 | 30 | 15 | 503 |
| 2022 | 22 | 10 | 276 |
| 2021 | 17 | 4 | 283 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
72 daysMedian, submission to acceptance · P25–P75 43 days – 99 days
- Acceptance to online
- median 17 days (45 articles)
- Submission to online
- median 82 days
- Sample
- 30 articles with submission and acceptance dates (44 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 9 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,890 / GBP 2,490 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted5
- commentaryReviews and Invited Commentaries Back to topLength not stated
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. Editorial Procedure—additional information This journal follows a single-blind…Length not stated
- invited commentariesTypes of papers Reviews and Invited CommentariesLength not stated
- reviewReviews and Invited Commentaries Back to topLength not stated
- reviewsTypes of papers Reviews and Invited CommentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI Images
LLMs do not satisfy authorship criteria Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure required Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
COPE member Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Fungal Infection Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure.
Source ↗Publisher website ·- Plagiarism
Plagiarism screening at submission Model summary
Upon submission, articles are run through plagiarism detection software to check for any issues or discrepancies.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 1936-3761
- Electronic ISSN
- 1936-377X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Fungal Infection Reports
What CAS zone is Current Fungal Infection Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Fungal Infection Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Fungal Infection Reports?
The journal's website gives an impact factor of 3.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 6, h-index 43.
How long does peer review take at Current Fungal Infection Reports?
Based on the dates recorded on 30 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 43–99 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Fungal Infection Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Fungal Infection Reports based?
Of the 3 board members whose country the journal's board page names, 1 (about 33%) are in mainland China; the countries named most often are Mexico (2) and Mainland China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Fungal Infection Reports?
According to LetPub and DOAJ records, Current Fungal Infection Reports is indexed in ESCI and Scopus. The journal's website also lists Embase and CAB Abstracts; that list has not been checked against each database.
Is Current Fungal Infection Reports open access, and what is the APC?
Current Fungal Infection Reports is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .